{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:01:15Z","timestamp":1766901675238,"version":"3.48.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10890-9","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T10:37:20Z","timestamp":1754390240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polymorphisms in cancer-related genes and their association with breast cancer risk in Iranian women"],"prefix":"10.1007","volume":"52","author":[{"given":"Atefeh","family":"Liravi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massoud","family":"Houshmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Jafarinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Forouzanfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"5","key":"10890_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386","journal-title":"Int J Cancer"},{"issue":"2","key":"10890_CR2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.30699\/ijbd.16.2.55","volume":"16","author":"F Rostampour","year":"2023","unstructured":"Rostampour F et al (2023) Risk factors for breast cancer in urmia: a case-control study. Iranian J Breast Dis 16(2):55\u201356","journal-title":"Iranian J Breast Dis"},{"issue":"57","key":"10890_CR3","doi-asserted-by":"crossref","first-page":"97217","DOI":"10.18632\/oncotarget.21743","volume":"8","author":"L-Y Liu","year":"2017","unstructured":"Liu L-Y et al (2017) A case-control study on risk factors of breast cancer in Han Chinese women. Oncotarget 8(57):97217","journal-title":"Oncotarget"},{"issue":"2","key":"10890_CR4","first-page":"171","volume":"104","author":"KP Trayes","year":"2021","unstructured":"Trayes KP, Cokenakes SE (2021) Breast cancer treatment. Am Fam Physician 104(2):171\u2013178","journal-title":"Am Fam Physician"},{"issue":"3","key":"10890_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/erc.0.0070165","volume":"7","author":"C Powers","year":"2000","unstructured":"Powers C, McLeskey S, Wellstein A (2000) Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7(3):165\u2013197","journal-title":"Endocr Relat Cancer"},{"key":"10890_CR6","volume-title":"Emery and Rimoin\u2019s essential medical genetics","author":"DL Rimoin","year":"2013","unstructured":"Rimoin DL, Pyeritz RE, Korf B (2013) Emery and Rimoin\u2019s essential medical genetics. Elsevier"},{"key":"10890_CR7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1201\/9781003246244-14","volume-title":"Genetic polymorphism and disease","author":"SS Aga","year":"2022","unstructured":"Aga SS et al (2022) Role of single nucleotide polymorphisms (SNPs) in common migraine. Genetic polymorphism and disease. CRC Press, pp 329\u2013340"},{"key":"10890_CR8","volume-title":"Biogeography: an ecological and evolutionary approach","author":"CB Cox","year":"2016","unstructured":"Cox CB, Moore PD, Ladle RJ (2016) Biogeography: an ecological and evolutionary approach. Wiley"},{"issue":"1","key":"10890_CR9","first-page":"747318","volume":"2013","author":"P Apostolou","year":"2013","unstructured":"Apostolou P, Fostira F (2013) Hereditary breast cancer: the era of new susceptibility genes. BioMed Res Int 2013(1):747318","journal-title":"BioMed Res Int"},{"issue":"1","key":"10890_CR10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2478\/v10019-010-0054-4","volume":"45","author":"T Ovcaricek","year":"2011","unstructured":"Ovcaricek T et al (2011) Triple negative breast cancer-prognostic factors and survival. Radiol Oncol 45(1):46\u201352","journal-title":"Radiol Oncol"},{"issue":"14","key":"10890_CR11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/jnci\/92.14.1126","volume":"92","author":"A-M Martin","year":"2000","unstructured":"Martin A-M, Weber BL (2000) Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 92(14):1126\u20131135","journal-title":"J Natl Cancer Inst"},{"key":"10890_CR12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13402-011-0010-3","volume":"34","author":"P Van Der Groep","year":"2011","unstructured":"Van Der Groep P, Van Der Wall E, Van Diest PJ (2011) Pathology of hereditary breast cancer. Cell Oncol 34:71\u201388","journal-title":"Cell Oncol"},{"issue":"11","key":"10890_CR13","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.21037\/tcr-20-1756","volume":"9","author":"W Wei","year":"2020","unstructured":"Wei W et al (2020) Fibroblast growth factor receptor 4 as a prognostic indicator in triple-negative breast cancer. Transl Cancer Res 9(11):6881","journal-title":"Transl Cancer Res"},{"issue":"8","key":"10890_CR14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.18632\/aging.100786","volume":"7","author":"B Belletti","year":"2015","unstructured":"Belletti B, Baldassarre G (2015) Roles of CDKN1B in cancer? Aging (Albany NY) 7(8):529","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10890_CR15","doi-asserted-by":"crossref","first-page":"28436","DOI":"10.1038\/srep28436","volume":"6","author":"V Eterno","year":"2016","unstructured":"Eterno V et al (2016) AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128. Sci Rep 6(1):28436","journal-title":"Sci Rep"},{"key":"10890_CR16","doi-asserted-by":"crossref","first-page":"597434","DOI":"10.3389\/fonc.2020.597434","volume":"10","author":"X Song","year":"2020","unstructured":"Song X et al (2020) Role of GPX4-mediated ferroptosis in the sensitivity of triple negative breast cancer cells to gefitinib. Front Oncol 10:597434","journal-title":"Front Oncol"},{"key":"10890_CR17","volume-title":"The p53 protein: from cell regulation to cancer","author":"G Lozano","year":"2016","unstructured":"Lozano G, Levine AJ (2016) The p53 protein: from cell regulation to cancer. Cold Spring Harbor Laboratory Press"},{"issue":"1","key":"10890_CR18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12920-023-01484-0","volume":"16","author":"F Afzaljavan","year":"2023","unstructured":"Afzaljavan F et al (2023) Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran. BMC Med Genomics 16(1):72","journal-title":"BMC Med Genomics"},{"key":"10890_CR19","first-page":"3945","volume":"25","author":"S Gopukumar","year":"2021","unstructured":"Gopukumar S et al (2021) In silico study of single nucleotide polymorphisms by polg2 gene. Ann Romanian Soc Cell Biol 25:3945\u20133954","journal-title":"Ann Romanian Soc Cell Biol"},{"key":"10890_CR20","unstructured":"Lemeshow S (1990) Adequacy of sample size in health studies. (No Title)"},{"issue":"1","key":"10890_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-023-01805-y","volume":"22","author":"F Ye","year":"2023","unstructured":"Ye F et al (2023) Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer 22(1):105","journal-title":"Mol Cancer"},{"key":"10890_CR22","doi-asserted-by":"crossref","first-page":"891824","DOI":"10.3389\/fonc.2022.891824","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Global burden of female breast cancer: age-period-cohort analysis of incidence trends from 1990 to 2019 and forecasts for 2035. Front Oncol 12:891824","journal-title":"Front Oncol"},{"issue":"4","key":"10890_CR23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaoncol.2017.4881","volume":"4","author":"EM van Veen","year":"2018","unstructured":"van Veen EM et al (2018) Use of single-nucleotide polymorphisms and mammographic density plus classic risk factors for breast cancer risk prediction. JAMA Oncol 4(4):476\u2013482","journal-title":"JAMA Oncol"},{"key":"10890_CR24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gde.2015.01.004","volume":"30","author":"L Fachal","year":"2015","unstructured":"Fachal L, Dunning AM (2015) From candidate gene studies to GWAS and post-GWAS analyses in breast cancer. Curr Opin Genet Dev 30:32\u201341","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"10890_CR25","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1038\/s41467-021-24327-x","volume":"12","author":"B Adedokun","year":"2021","unstructured":"Adedokun B et al (2021) Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. Nat Commun 12(1):4198","journal-title":"Nat Commun"},{"issue":"3","key":"10890_CR26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng.1049","volume":"44","author":"M Ghoussaini","year":"2012","unstructured":"Ghoussaini M et al (2012) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 44(3):312\u2013318","journal-title":"Nat Genet"},{"issue":"14","key":"10890_CR27","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1093\/hmg\/ddq174","volume":"19","author":"X Wang","year":"2010","unstructured":"Wang X et al (2010) Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 19(14):2886\u20132897","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10890_CR28","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.18632\/oncotarget.24064","volume":"9","author":"G-P Xu","year":"2018","unstructured":"Xu G-P et al (2018) The association between BRCA1 gene polymorphism and cancer risk: a meta-analysis. Oncotarget 9(9):8681","journal-title":"Oncotarget"},{"key":"10890_CR29","doi-asserted-by":"crossref","first-page":"BCBCR S18715","DOI":"10.4137\/BCBCR.S18715","volume":"8","author":"MJ Larsen","year":"2014","unstructured":"Larsen MJ et al (2014) Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer Basic Clin Res 8:BCBCR S18715","journal-title":"Breast Cancer Basic Clin Res"},{"issue":"3","key":"10890_CR30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4103\/1735-1995.156178","volume":"20","author":"H Neamatzadeh","year":"2015","unstructured":"Neamatzadeh H, Shiryazdi SM, Kalantar SM (2015) BRCA1 and BRCA2 mutations in Iranian breast cancer patients: a systematic review. J Res Med Sci 20(3):284\u2013293","journal-title":"J Res Med Sci"},{"issue":"4","key":"10890_CR31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.prp.2018.02.004","volume":"214","author":"GJ Kim","year":"2018","unstructured":"Kim GJ et al (2018) Loss of p27kip1 expression is associated with poor prognosis in patients with taxane-treated breast cancer. Pathology-Research and Practice 214(4):565\u2013571","journal-title":"Pathology-Research and Practice"},{"issue":"1","key":"10890_CR32","doi-asserted-by":"crossref","first-page":"44871","DOI":"10.1038\/srep44871","volume":"7","author":"X-K Cheng","year":"2017","unstructured":"Cheng X-K et al (2017) Genetic association between the cyclin-dependent kinase inhibitor gene p27\/Kip1 polymorphism (rs34330) and cancer susceptibility: a meta-analysis. Sci Rep 7(1):44871","journal-title":"Sci Rep"},{"key":"10890_CR33","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1007\/s11033-013-2751-8","volume":"40","author":"H Xiang","year":"2013","unstructured":"Xiang H et al (2013) Association of CDKN1B gene polymorphisms with susceptibility to breast cancer: a meta-analysis. Mol Biol Rep 40:6371\u20136377","journal-title":"Mol Biol Rep"},{"issue":"9","key":"10890_CR34","first-page":"2705","volume":"10","author":"X Lin","year":"2020","unstructured":"Lin X et al (2020) The role of aurora-a in human cancers and future therapeutics. Am J Cancer Res 10(9):2705","journal-title":"Am J Cancer Res"},{"issue":"7","key":"10890_CR35","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1055-9965.EPI-07-0129","volume":"16","author":"FJ Couch","year":"2007","unstructured":"Couch FJ et al (2007) AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1\/2 study. Cancer Epidemiol Biomark Prev 16(7):1416\u20131421","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"16","key":"10890_CR36","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.7314\/APJCP.2014.15.16.6709","volume":"15","author":"X-G Guo","year":"2014","unstructured":"Guo X-G et al (2014) The AURKA gene rs2273535 polymorphism contributes to breast carcinoma risk-meta-analysis of eleven studies. Asian Pac J Cancer Prev 15(16):6709\u20136714","journal-title":"Asian Pac J Cancer Prev"},{"key":"10890_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-14-1","volume":"14","author":"Z-J Dai","year":"2014","unstructured":"Dai Z-J et al (2014) Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects. Cancer Cell Int 14:1\u20138","journal-title":"Cancer Cell Int"},{"key":"10890_CR38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fphys.2018.01124","volume":"9","author":"X Zhou","year":"2018","unstructured":"Zhou X, Wang P, Zhao H (2018) The association between AURKA gene rs2273535 polymorphism and gastric cancer risk in a Chinese population. Front Physiol 9:1124","journal-title":"Front Physiol"},{"issue":"5","key":"10890_CR39","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072","journal-title":"Cell"},{"key":"10890_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1680-4","volume":"15","author":"E Jablonska","year":"2015","unstructured":"Jablonska E et al (2015) Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1. BMC Cancer 15:1\u201312","journal-title":"BMC Cancer"},{"issue":"24","key":"10890_CR41","doi-asserted-by":"crossref","first-page":"15762","DOI":"10.3390\/ijms232415762","volume":"23","author":"P Barbosa","year":"2022","unstructured":"Barbosa P et al (2022) The role of rs713041 glutathione peroxidase 4 (GPX4) single nucleotide polymorphism on disease susceptibility in humans: a systematic review and meta-analysis. Int J Mol Sci 23(24):15762","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10890_CR42","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1172\/JCI26252","volume":"115","author":"IN Lavrik","year":"2005","unstructured":"Lavrik IN, Golks A, Krammer PH (2005) Caspases: pharmacological manipulation of cell death. J Clin Invest 115(10):2665\u20132672","journal-title":"J Clin Invest"},{"issue":"3","key":"10890_CR43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng1981","volume":"39","author":"A Cox","year":"2007","unstructured":"Cox A et al (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39(3):352\u2013358","journal-title":"Nat Genet"},{"issue":"24","key":"10890_CR44","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/jnci\/dji001","volume":"96","author":"G MacPherson","year":"2004","unstructured":"MacPherson G et al (2004) Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 96(24):1866\u20131869","journal-title":"J Natl Cancer Inst"},{"key":"10890_CR45","doi-asserted-by":"crossref","first-page":"173201","DOI":"10.1016\/j.ejphar.2020.173201","volume":"881","author":"M Hashemi","year":"2020","unstructured":"Hashemi M et al (2020) Association of CASP8 polymorphisms and cancer susceptibility: a meta-analysis. Eur J Pharmacol 881:173201","journal-title":"Eur J Pharmacol"},{"key":"10890_CR46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-009-0471-5","volume":"120","author":"TN Sergentanis","year":"2010","unstructured":"Sergentanis TN, Economopoulos KP (2010) Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 120:229\u2013234","journal-title":"Breast Cancer Res Treat"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10890-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:27:37Z","timestamp":1766896057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10890-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10890"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10890-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"793"}}